A Phase 2 Study in Patients With Alzheimer's Disease to assess the efficacy of VG-3927
Latest Information Update: 27 May 2025
At a glance
- Drugs VG 3927 (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
Most Recent Events
- 27 May 2025 New trial record